Liver toxicity

Veterinary Toxicology

Volumn , Issue , 2007, Pages 145-160

  Bischoff, Karyn ^a   Ramaiah, Shashi K ^b  

^a Department of Obstetrics Gynecology   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651337787     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012370467-2/50107-3     Document Type: Chapter

References (58)

1. Amacher DE, Adler R, Herath A Use of proteomic methods to identify serum markers associated with rat liver toxicity or hypertrophy. Clin Chem 2005, 51:1796-1803.
2. Apte UM, McRee R, Ramaiah SK Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury dur-ing steatosis stage of alcoholic liver disease. Toxicol Path 2004, 32:567-576.
3. Banerjee A, Apte UM, Smith III R, Ramaiah SK Higher neu-trophil infiltration mediated by osteopontin is the likely con-tributing factor for increased susceptibility of females to Alcoholic Liver Disease. J Pathol 2006, 208:473-485.
4. Bardag-Gorce F, Yuan QX, Li J, French BA, Fang C, Ingelman-Sundberg M, French SW The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. Biochem Biophys Res Commun 2000, 279:23-29.
5. Bastianello SS, Nesbit JW, Williams MC, et al. Pathological find-ings in a natural outbreak of aflatoxicosis in dogs. Onderstepoort J Vet Res 1987, 54:635-640.
6. Bautista AP Neutrophilic infiltration in alcoholic hepatitis. Alcohol 2002, 27:17-21.
7. Brown SA Pharmakokinetics: disposition and fate of drugs in the body. Veterinary Pharmacology and Therapeutics 2001, 15-56. Iowa State University Press, Ames, IA. 8th edn. R. Adams (Ed.).
8. Burrows GE, Tyrl RJ Toxic Plants of North America 2001, 1196-1200. Iowa State University Press, Ames, IA.
9. Center SA, Elston TH, Rowland PH, et al. Fulminant hepatic failure associated with oral administration of diazepam in 11 cats. J Am Vet Med Assoc 1996, 209:618-625.
10. Court MH, Greenblatt DJ Molecular basis for deficient acetaminophen glucuronidation in cats. Biochem Pharmacol 1997, 5:1041-1047.
11. Crawford JM The liver and the biliary tract. Robbins: Pathologic Basis of Disease 1999, 845-901. Saunders, Philadelphia. 6th edn. R.S. Cotran, V. Kumar, T. Collins (Eds.).
12. Cullen JM Mechanistic Classification of Liver injury. Tox Pathol 2005, 33:6-8.
13. Cullen JM, Ruenber BH Ahistopathologic classification of chemical-induced injury of the liver. Hepatotoxicology 1991, 67-92. CRC Press, Boca Raton, PA. R.G. Meeks, S.D. Harrison, R.J. Bull (Eds.).
14. Dahm LJ, Jones DP Mechanisms of chemically induced liver disease. Hepatology, A Textbook of Liver Disease 1996, 875-890. W.B. Saunders Company, Philadelphia. D. Zakim, T.D. Boyer (Eds.).
15. 2+-ATPase in the hepatocyte?. Mol Cell Biochem 2006, (Epub Ahead of print).
16. Diehl AM Liver disease in alcohol abusers: Clinical Perspective. Alcohol 2002, 27:7-11.
17. DiLuzio NR A mechanism of the acute ethanol-induced fatty liver and the modification of liver injury by antioxidants. Lab Invest 1966, 15:50-63.
18. Farrell GC, Duddy SK, Kass GE, Llopis J, Gahm A, Orrenius S Release of calcium from the endoplasmic reticulum is not the mechanism for bile acid induced cholestasis and hepatotoxicity in the intact rat liver. J Clin Invest 1990, 85:1255-1259.
19. French SW Alcoholic liver disease. Hepatology, A text book of liver disease 2003, 839-922. W.B. Saunders, Philadelphia. D. Zakim, T.D. Moyer (Eds.).
20. Hoek JB, Pastorino JG Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002, 27:63-68.
21. Houten BV, Woshner V, Santos JH Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair 2006, 5:145-152.
22. Jaeschke H, Bajt ML Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Tox Sci 2006, 89:31-41.
23. Jaeschke H, Gujral JS, Bajt ML Apoptosis and necrosis in liver disease. Liver Int 2004, 24:85-89.
24. Jean PA, Roth RA Napthylisothiocyanate disposition in bile and its relationship to liver glutathione and toxicity. Biochem Pharmacol 1995, 50:1469-1474.
25. Klaassen CD, Slitt AL Regulation of hepatic transporters by xenobiotic receptors. Curr Drug Metab 2005, 6:309-328.
26. Kono H, Rusyn I, Connor H, Mason RP, Thurman RG Allopurinol prevents early alcohol-induced liver injury in rats. J Pharmacol Exp Therapeut 2000, 293:296-303.
27. Laskin DL Nonparenchymal cells and hepatotoxicity. Semin Liver Dis 1990, 10:293-304.
28. Levin S, Bucci TJ, Cohen SM, Fix AS, Hardisty JF, LeGrand EK, Maronpot RR, Trump BF The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists. Toxicol Pathol 1999, 27:484-490.
29. Lieber CS Alcohol and the liver: 1994 update. Gastroenterology 1994, 106:1085-1105.
30. Lieber CS, Decarli LM Animal models of ethanol dependence and liver injury in rats and baboons. Fed Proc 1976, 35:1232-1236.
31. MacPhail CM, Lappin MR, Meyer DJ, et al. Hepatocellular tox-icosis associated with administration of carprofen in 21 dogs. JAm Vet Med Assoc 1998, 12:895-1901.
32. Maddrey WC Drug-induced hepatotoxicity: 2005. J Clin Gastroenterol 2005, 39:S83-S89.
33. Malhi H, Gores GJ, Lemasters JJ Apoptosis and necrosis in the liver: A tale of two deaths?. Hepatology 2006, 43:S31-S44.
34. Mehendale HM Tissue repair: an important determinant of final outcome of toxicant-induced injury. Tox Pathol 2005, 33:41-51.
35. Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis: IV. Protective role of glutathione. J Pharmacol Exp Ther 1973, 187:211-217.
36. Newberne PM, Butler WH Acute and chronic effects of afla-toxin on the liver of domestic and laboratory animals: a review. Cancer Res 1969, 29:236-250.
37. Oldham-Ott CK, Gilloteaux J Comparative morphology of the gallbladder and biliary tract in vertebrates: variation in structure, homology in function and gallstones. Microsc Res Tech 1997, 38:571-598.
38. Piñeiro-Carrero VM, Piñeiro EO Liver. Pediatrics 2004, 113:2097-2106.
39. Plumlee KH Hepatobiliary system. Clinical Veterinary Toxicology 2004, 61-68. Mosby, St Louis. K.H. Plumlee (Ed.).
40. Ramaiah SK, Mehendale HM Diet restriction as a protective mechanism in non cancer toxicity outcomes: a review. Int J Toxicol 2000, 19:413-424.
41. Ramaiah SK, Soni MG, Bucci TJ, Mehendale HM Temporal changes in tissue repair permit survival of diet restricted rats from acute lethal dose of thioacetamide. Toxicol Sci 1998, 45:233-241.
42. Ramaiah SK, Rivera C, Arteel G Early phase alcoholic liver disease: An update on animal models pathology and pathogenesis 2004, 23:217-231.
43. Reynolds ES, Moslen MT Environmental liver injury: Halogenated hydrocarbons. Toxic Injury of the Liver 1980, 541-596. Marcel Dekker, New York. E. Farber, M.M. Fisher (Eds.).
44. Rolfe DS, Twedt DC Copper associated hepatopathies in dogs. Vet Clin North Am Small Anim Pract 1995, 25:399-417.
45. Rowe LD Photosensitization problems in livestock. Vet Clin North Am Food. Anim Pract 1989, 5:301-323.
46. Shenton JM, Chen J, Uetrect JP Animal models of idiosyncratic drug reactions. Chemico-Biol Interact 2004, 150:53-70.
47. Sturgill MG, Lambert GH Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin Chem 1997, 43:1512-1526.
48. Thurman RG, Bradford BU, Iimuro Y, Knecht KT, Arteel GE, Yin M The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury. J Gastroenterol Hepatol 1998, 13:S39-S50.
49. Treinen-Moslen M Toxic Responses of the Liver. Casarette & Doull's Toxicology The Basic Science of Poisons 2001, 471-489. McGraw Hill, Columbus, OH. C.D. Klaassen (Ed.).
50. Trepanier LA Idiosyncratic toxicity associated with potenti-ated sulfonamides in the dog. J Vet Pharmacol Therap 2004, 27:129-138.
51. Trepanier LA, Danhof R, Toll J, et al. Clinical findings in 40 dogs with hypersensitivity associated with administration of potentiated sulfonamides. J Vet Intern Med 2003, 17:647-652.
52. Uchida H, Tomikawa S, Nishimura Y, et al. Vanishing bile duct syndrome in canine liver allotransplants. Transplant Proc 1989, 21:404-406.
53. Wallace KB, Eells JT, Madeira VM Mitochondria-mediated cell injury. Symposium Overview. Fundam Appl Toxicol 1997, 38:23-37.
54. Watkins PB Mechanisms of drug induced liver disease. Schiff's Diseases of the Liver 1999, 1065-1080. Lippincott-Raven Publishers, Philidelphia. E.R. Schiff, M.F. Sorrell, W.F. Maddrey (Eds.).
55. Watkins PB, Seeff LB Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 2006, 43:618-631.
56. Xu C, Li CY, Kong AN Induction of phase I, II, and III drug metabolism/transport by xenobiotics. Arch Pharm Res 2005, 28:249-268.
57. Yee SB, Harkema JR, Ganey PE, et al. The coagulation system contributes to synergistic liver injury from exposure to monocro-taline and bacterial lipopolysaccharide. Tox Sci 2003, 74:457-469.
58. Zimmerman HJ Drug induced liver disease. Schiff's Diseases of the Liver 1999, 973-1064. Lippincott-Raven Publishers, Philidelphia. E.R. Schiff, M.F. Sorrell, W.F. Maddrey (Eds.).